PK and Safety in Participants Taking Obicetrapib With Moderate Hepatic Impairment Relative to Normal Hepatic Function

Clinical trial NCT06048302 · COMPLETED

Trial details

NCT number: NCT06048302
Sponsor: NewAmsterdam Pharma
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Hepatic Impairment Healthy

Start date: 2023-11-30
Primary completion: 2024-03-12
Enrollment: 18

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.